Sphera Funds Management Ltd. 89bio, Inc. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 536,547 shares of ETNB stock, worth $3.69 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
536,547
Previous 526,547
1.9%
Holding current value
$3.69 Million
Previous $4.22 Million
5.86%
% of portfolio
0.73%
Previous 0.62%
Shares
12 transactions
Others Institutions Holding ETNB
# of Institutions
159Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$104 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$97.5 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$55 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$50.8 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$48.3 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $320M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...